Search by Drug Name or NDC

    NDC 00143-9141-10 Dobutamine 12.5 mg/mL Details

    Dobutamine 12.5 mg/mL

    Dobutamine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is DOBUTAMINE HYDROCHLORIDE.

    Product Information

    NDC 00143-9141
    Product ID 0143-9141_06e5d151-bd26-4c5e-b84a-1a11a3147327
    Associated GPIs
    GCN Sequence Number 064535
    GCN Sequence Number Description dobutamine HCl VIAL 250MG/20ML INTRAVEN
    HIC3 A1C
    HIC3 Description INOTROPIC DRUGS
    GCN 14575
    HICL Sequence Number 000040
    HICL Sequence Number Description DOBUTAMINE HCL
    Brand/Generic Generic
    Proprietary Name Dobutamine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dobutamine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 12.5
    Active Ingredient Units mg/mL
    Substance Name DOBUTAMINE HYDROCHLORIDE
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074277
    Listing Certified Through 2024-12-31

    Package

    NDC 00143-9141-10 (00143914110)

    NDC Package Code 0143-9141-10
    Billing NDC 00143914110
    Package 10 VIAL in 1 CARTON (0143-9141-10) / 20 mL in 1 VIAL
    Marketing Start Date 2023-05-03
    NDC Exclude Flag N
    Pricing Information N/A